We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$146M
AUM Growth
+$7.73M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$65.9M 45.01%
3,931,818
TECX
2
Tectonic Therapeutic
TECX
$578M
$47.5M 32.46%
1,028,674
KYTX icon
3
Kyverna Therapeutics
KYTX
$481M
$16.9M 11.56%
4,523,924
DYN icon
4
Dyne Therapeutics
DYN
$4.24B
$9.6M 6.56%
407,499
ALLO icon
5
Allogene Therapeutics
ALLO
$604M
$3.83M 2.62%
1,798,163
KRON
6
DELISTED
Kronos Bio
KRON
$2.63M 1.8%
2,765,314

Similar funds

Vida Ventures Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Vida Ventures Advisors held 6 positions worth $146M, up 5.6% from $139M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 0%. Vida Ventures Advisors opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors's ten largest holdings make up 100% of its $146M portfolio in Q4 2024.
  • Vida Ventures Advisors opened 0 new positions and closed 0 in Q4 2024.
  • Vida Ventures Advisors's portfolio value rose 5.6% quarter-over-quarter to $146M.

Based on Vida Ventures Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.